These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24470517)

  • 1. Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population?
    Speeckaert M; Van Biesen W; Delanghe J; Slingerland R; Wiecek A; Heaf J; Drechsler C; Lacatus R; Vanholder R; Nistor I;
    Nephrol Dial Transplant; 2014 Dec; 29(12):2167-77. PubMed ID: 24470517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment.
    Konya J; Ng JM; Cox H; Cooke M; Lewis N; Bhandari S; Atkin SL; Kilpatrick ES
    Diabet Med; 2013 Oct; 30(10):1250-4. PubMed ID: 23758176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The agreement between fasting glucose and markers of chronic glycaemic exposure in individuals with and without chronic kidney disease: a cross-sectional study.
    George C; Matsha TE; Korf M; Zemlin AE; Erasmus RT; Kengne AP
    BMC Nephrol; 2020 Jan; 21(1):32. PubMed ID: 32000712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Use of HbA1c, Glycated Albumin and Continuous Glucose Monitoring to Assess Glucose Control in the Chronic Kidney Disease Population Including Dialysis.
    Bomholt T; Adrian T; Nørgaard K; Ranjan AG; Almdal T; Larsson A; Vadstrup M; Rix M; Feldt-Rasmussen B; Hornum M
    Nephron; 2021; 145(1):14-19. PubMed ID: 33264783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease.
    Zelnick LR; Batacchi ZO; Ahmad I; Dighe A; Little RR; Trence DL; Hirsch IB; de Boer IH
    Diabetes Care; 2020 Oct; 43(10):2379-2387. PubMed ID: 32788282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond self-monitored plasma glucose and HbA1c: the role of non-traditional glycaemic markers in gestational diabetes mellitus.
    Mendes N; Tavares Ribeiro R; Serrano F
    J Obstet Gynaecol; 2018 Aug; 38(6):762-769. PubMed ID: 29620435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease - cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort.
    Busch M; Nadal J; Schmid M; Paul K; Titze S; Hübner S; Köttgen A; Schultheiss UT; Baid-Agrawal S; Lorenzen J; Schlieper G; Sommerer C; Krane V; Hilge R; Kielstein JT; Kronenberg F; Wanner C; Eckardt KU; Wolf G;
    BMC Nephrol; 2016 Jun; 17(1):59. PubMed ID: 27286816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes mellitus in chronic kidney disease: Biomarkers beyond HbA1c to estimate glycemic control and diabetes-dependent morbidity and mortality.
    Copur S; Onal EM; Afsar B; Ortiz A; van Raalte DH; Cherney DZ; Rossing P; Kanbay M
    J Diabetes Complications; 2020 Nov; 34(11):107707. PubMed ID: 32861562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of glycemia in chronic kidney disease.
    Hassanein M; Shafi T
    BMC Med; 2022 Apr; 20(1):117. PubMed ID: 35414081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Dietary Glycaemic Index on Glycaemia in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Ojo O; Ojo OO; Adebowale F; Wang XH
    Nutrients; 2018 Mar; 10(3):. PubMed ID: 29562676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications and pitfalls of hemoglobin A1C and alternative methods of glycemic monitoring.
    Lundholm MD; Emanuele MA; Ashraf A; Nadeem S
    J Diabetes Complications; 2020 Aug; 34(8):107585. PubMed ID: 32553575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining the relationship between average glucose and HbA1c in patients with type 2 diabetes and chronic kidney disease.
    Lo C; Lui M; Ranasinha S; Teede HJ; Kerr PG; Polkinghorne KR; Nathan DM; Zheng H; Zoungas S
    Diabetes Res Clin Pract; 2014 Apr; 104(1):84-91. PubMed ID: 24573088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycated proteins as indices of glycaemic control in diabetic patients with chronic renal failure.
    Morgan L; Marenah CB; Jeffcoate WJ; Morgan AG
    Diabet Med; 1996 Jun; 13(6):514-9. PubMed ID: 8799653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence.
    Sany D; Elshahawy Y; Anwar W
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):260-73. PubMed ID: 23538348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A1C--frequently asked questions.
    Phillips PJ; Phillipov G
    Aust Fam Physician; 2005 Aug; 34(8):663-7. PubMed ID: 16113704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycated haemoglobin and fructosamine in non-diabetic subjects with chronic renal failure.
    Morgan LJ; Marenah CB; Morgan AG; Burden RP; John WG
    Nephrol Dial Transplant; 1990; 5(10):868-73. PubMed ID: 2128382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When 7 isn't 7: glycohemoglobin and chronic kidney disease.
    Oppenheimer M; Jensen R; Huntington MK
    S D Med; 2013 Feb; 66(2):59-61. PubMed ID: 23513360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring.
    Beck R; Steffes M; Xing D; Ruedy K; Mauras N; Wilson DM; Kollman C;
    Pediatr Diabetes; 2011 Dec; 12(8):690-5. PubMed ID: 21496193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How does CKD affect HbA1c?
    Bloomgarden Z; Handelsman Y
    J Diabetes; 2018 Apr; 10(4):270. PubMed ID: 29124865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.